Differential glycaemic control with basal insulin glargine 300
            U/mL
            versus degludec 100
            U/mL
            according to kidney function in type 2 diabetes: A subanalysis from the
            BRIGHT
            trial

Martin Haluzík; Alice Cheng; Dirk Müller‐Wieland; Jukka Westerbacka; Zsolt Bosnyak; Felipe Lauand; Lydie Melas‐Melt; Janaka Karalliedde; Julio Rosenstock; Geremia B. Bolli

doi:10.1111/dom.14043

Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14043 ◽

2020 ◽

Vol 22 (8) ◽

pp. 1369-1377 ◽

Cited By ~ 1

Author(s):

Martin Haluzík ◽

Alice Cheng ◽

Dirk Müller‐Wieland ◽

Jukka Westerbacka ◽

Zsolt Bosnyak ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Kidney Function ◽

Basal Insulin

Review for "Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes - a subanalysis from the BRIGHT trial"

10.1111/dom.14043/v2/review4 ◽

2020 ◽

Author(s):

Tomislav Bozek

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Kidney Function ◽

Basal Insulin

Review for "Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes - a subanalysis from the BRIGHT trial"

10.1111/dom.14043/v2/review3 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Kidney Function ◽

Basal Insulin

Author response for "Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes - a subanalysis from the BRIGHT trial"

10.1111/dom.14043/v2/response1 ◽

2020 ◽

Author(s):

Martin Haluzík ◽

Alice Cheng ◽

Dirk Müller-Wieland ◽

Jukka Westerbacka ◽

Zsolt Bosnyak ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Kidney Function ◽

Basal Insulin ◽

Author Response

Decision letter for "Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes - a subanalysis from the BRIGHT trial"

10.1111/dom.14043/v1/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Kidney Function ◽

Basal Insulin

Decision letter for "Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes - a subanalysis from the BRIGHT trial"

10.1111/dom.14043/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Kidney Function ◽

Basal Insulin

Review for "Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes - a subanalysis from the BRIGHT trial"

10.1111/dom.14043/v1/review5 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Kidney Function ◽

Basal Insulin

Review for "Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes - a subanalysis from the BRIGHT trial"

10.1111/dom.14043/v1/review4 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Kidney Function ◽

Basal Insulin

Review for "Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes - a subanalysis from the BRIGHT trial"

10.1111/dom.14043/v2/review2 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Kidney Function ◽

Basal Insulin

Review for "Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes - a subanalysis from the BRIGHT trial"

10.1111/dom.14043/v2/review1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Kidney Function ◽

Basal Insulin

Review for "Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes - a subanalysis from the BRIGHT trial"

10.1111/dom.14043/v1/review3 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Kidney Function ◽

Basal Insulin